Dr. Surya Prakash Bhatt, MD

Dr. Bhatt practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Bhatt's NPI, 1396936746, was assigned on August 8, 2007. Dr. Bhatt holds Alabama license 31641.

Dr. Bhatt's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Bhatt's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Bhatt is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatt practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bhatt's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bhatt is licensed in Alabama.

CMS data shows 88 Medicare services from Dr. Bhatt across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $10,457 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Bhatt in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatt's median patient age at 67, with 56% women.

In 2024, Dr. Bhatt wrote 152 Medicare Part D claims for 32 patients. 57% of them were for generic drugs. CMS names the drug for 113 of them, across 6 drugs with 11 or more claims each, at $32,922 in total drug cost. In 2023, CMS named 101 claims across 5 drugs.

Dr. Bhatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Bhatt to 1 clinical trial. Conditions studied include Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive. Open Payments lists research payments to Dr. Bhatt that name 5 trials.

CMS Open Payments shows 316 general payments to Dr. Bhatt from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Sanofi and Genzyme US Companies paid the most, $315,026. It also lists 113 research payments totaling $40,867 from 2019 to 2025, naming 5 clinical trials.